Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, remains a significant health issue worldwide, particularly in developing nations. This article aims to provide an updated approach to its diagnosis and treatment, based on recent research and advancements.
Early diagnosis of enteric fever is crucial for effective management. Traditionally, blood culture has been the gold standard for diagnosis. However, its sensitivity is not optimal, especially in early disease stages or after antibiotic therapy. Recent advancements include nucleic acid amplification tests (NAATs), which have shown promising results in terms of sensitivity and specificity. Moreover, serological tests like Typhidot and Tubex have improved, although their reliability varies across different populations.
Treatment of enteric fever mainly involves antibiotic therapy. The choice of antibiotics has evolved due to increasing antibiotic resistance. Fluoroquinolones, once the first-line treatment, have seen decreased efficacy due to widespread resistance. Current guidelines recommend third-generation cephalosporins like ceftriaxone or cefixime, or azithromycin as first-line treatment. However, the choice should be guided by local susceptibility patterns. Moreover, supportive care including hydration and fever control is vital.
Prevention plays a key role in managing enteric fever. This includes provision of safe drinking water, improved sanitation, and vaccination. Two vaccines, Vi polysaccharide vaccine and Ty21a, are currently available. However, their use is recommended in high-risk areas or for travelers to such areas, as their efficacy is not 100%.
Enteric fever continues to pose a significant health challenge, especially in resource-limited settings. Early diagnosis and appropriate treatment are essential for patient recovery. The emergence of antibiotic resistance necessitates continuous surveillance and updating of treatment guidelines. Preventive strategies, including vaccination and improvements in water and sanitation, are equally important in controlling the disease.
1.
Hypnotherapy may offer real benefits for cancer patient care
2.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
3.
Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.
4.
Big Drop in Cervical Cancer Deaths; Publication Hijackers; A Win for CRC Home Tests
5.
Inadvertent lung cancer screening results are discussed in a new study.
1.
Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options
2.
Cellular Mechanisms of Hematopoietic Stress Adaptation During Repeated Physiological Demand
3.
The Growing Crisis of Aplastic Anemia: A Call for Action
4.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
5.
Case Study: Advancing Preclinical Oncology Drug Development with Quantitative Systems Pharmacology
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
3.
Early warning sings of camcer that need medical attention
4.
From Guidelines to Practice: Hematology
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation